13G FILING

Company

Emmaus Life Sciences, Inc.

Filed

February 8, 2008

Accession Number

0000937394-08-000040

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →